PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 3 months ago Inside Information / Other news releases Medincell achieves 25% increase in 2024 UZEDY® revenue outlook reaching $100M and key milestone in Olanzapine LAI Phase 3 clinical trials. Teva Pharmaceuticals shares Q3 results Revenue Clinical Trials Medincell Teva Pharmaceuticals UZEDY
BRIEF published on 10/01/2024 at 15:47, 1 year 4 months ago Franchissement de seuil par Mirova dans MEDINCELL Capital Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 10/01/2024 at 15:47, 1 year 4 months ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 10/01/2024 at 15:42, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds gérés, détenant 7,07% du capital et 5,01% des droits de vote de MEDINCELL Acquisition Franchissement De Seuil AMF Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 1 year 4 months ago Teva et Medincell Présentent des Résultats Prometteurs sur l'Olanzapine LAI pour la Schizophrénie Schizophrénie Essai Clinique Medincell Teva Olanzapine LAI
BRIEF published on 09/24/2024 at 11:54, 1 year 4 months ago Teva and Medincell Present Promising Results on Olanzapine LAI for Schizophrenia Clinical Trial Schizophrenia Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:53, 1 year 4 months ago Inside Information / Other news releases Teva and Medincell reveal positive efficacy, safety, and tolerability data from Phase 3 study on Olanzapine LAI for schizophrenia treatment, presenting at ECNP 2024 Schizophrenia Treatment Phase 3 Study Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:49, 1 year 4 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Teva présente de nouvelles données sur l'efficacité de l'olanzapine LAI pour la schizophrénie lors de l'ENCP 2024. Collaboration Teva-Medincell pour développement Schizophrénie Efficacité Medincell Teva ENCP 2024
BRIEF published on 09/18/2024 at 10:13, 1 year 4 months ago Mirova franchit le seuil des 5% des droits de vote de MEDINCELL Droits De Vote Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 09/18/2024 at 10:13, 1 year 4 months ago Mirova crosses the threshold of 5% of voting rights in MEDINCELL Voting Rights Actions Threshold Crossing Medincell Mirova
Published on 02/07/2026 at 01:00, 1 day 6 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 8 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 9 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 15 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 17 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 10 hours 18 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 14 hours 43 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 14 hours 58 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 11 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 13 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 12 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 12 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 15 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 15 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 23 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
